Back

Will ACE inhibitors be abandoned in the treatment of HFrEF?

27 August 2017 (16:30 - 16:52)
Organised by:
Congress Presentation Part of: The future therapy of heart failure: shall we find the answers in the crystal ball? AHF - Drug treatment ESC Premium Access ESC Congress 2017

About the speaker

Photo
Professor John J V McMurray

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Should beta-blockers be stopped in HFrEF and atrial fibrillation?
Professor T. McDonagh (London, GB)
Slides Video
Presentation thumbnail
Will we use VADs to recover the failing heart in the future?
Doctor S. Drakos (Salt Lake City, US)
Slides Video
Presentation thumbnail
The path to leadless CRT.
Professor J. Cleland (Glasgow, GB)
Slides Video

Access the full session

Session thumbnail
The future therapy of heart failure: shall we find the answers in the crystal ball?

The Event

Event poster

ESC Congress 2017

27 August 2017 16:30 CET
You may be interested in
thumbnail
Congress Session
Is left ventricular ejection fraction still relevant for guideline-directed medical therapy implementation?
18 May 2025
thumbnail
Congress Presentation
Are ACE inhibitors still the cornerstone of cardiovascular protection?
27 August 2022
thumbnail
Congress Presentation
Efficacy and safety of sacubitril valsartan in heart failure compared to renin angiotensin aldosterone system inhibitors: a systematic review and meta analysis of randomised controlled trials
26 August 2022
thumbnail
Congress Presentation
Four pillars of HFrEF: pilot study with real-world data
20 March 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources